Loss of ARID1A expression is associated with poor prognosis in patients with stage I/II clear cell carcinoma of the ovary
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Loss of ARID1A expression is associated with poor prognosis in patients with stage I/II clear cell carcinoma of the ovary
Authors
Keywords
Ovarian carcinoma, Clear cell, ARID1A, Biomarker
Journal
International Journal of Clinical Oncology
Volume 20, Issue 5, Pages 967-973
Publisher
Springer Nature
Online
2015-03-05
DOI
10.1007/s10147-015-0811-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Loss of ARID1A expression sensitizes cancer cells to PI3K- and AKT-inhibition
- (2015) Eleftherios P. Samartzis et al. Oncotarget
- A functional proteogenomic analysis of endometrioid and clear cell carcinomas using reverse phase protein array and mutation analysis: protein expression is histotype-specific and loss of ARID1A/BAF250a is associated with AKT phosphorylation
- (2014) Kimberly C Wiegand et al. BMC CANCER
- Gynecologic Cancer InterGroup (GCIG) Consensus Review for Clear Cell Carcinoma of the Ovary
- (2014) Aikou Okamoto et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Decreased ARID1A expression is correlated with chemoresistance in epithelial ovarian cancer
- (2014) Yoshihito Yokoyama et al. Journal of Gynecologic Oncology
- The Chromatin Remodeling Gene ARID1A Is a New Prognostic Marker in Clear Cell Renal Cell Carcinoma
- (2013) Zsuzsanna Lichner et al. AMERICAN JOURNAL OF PATHOLOGY
- Loss of ARID1A Expression Correlates With Stages of Tumor Progression in Uterine Endometrioid Carcinoma
- (2013) Tsui-Lien Mao et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Reduced expression of the chromatin remodeling gene ARID1A enhances gastric cancer cell migration and invasion via downregulation of E-cadherin transcription
- (2013) Hai-Bo Yan et al. CARCINOGENESIS
- Loss of ARID1A/BAF250a expression is linked to tumor progression and adverse prognosis in cervical cancer
- (2013) Hanbyoul Cho et al. HUMAN PATHOLOGY
- Frequent somatic mutations of the telomerase reverse transcriptase promoter in ovarian clear cell carcinoma but not in other major types of gynaecological malignancy
- (2013) Ren-Chin Wu et al. JOURNAL OF PATHOLOGY
- Ovarian cancers arising from endometriosis: A microenvironmental biomarker study including ER, HNF1ß, p53, PTEN, BAF250a, and COX-2
- (2013) Chiung-Ru Lai et al. Journal of the Chinese Medical Association
- Loss of ARID1A expression and its relationship with PI3K-Akt pathway alterations, TP53 and microsatellite instability in endometrial cancer
- (2013) Tjalling Bosse et al. MODERN PATHOLOGY
- Loss of ARID1A expression and its relationship with PI3K-Akt pathway alterations and ZNF217 amplification in ovarian clear cell carcinoma
- (2013) Hsien-Neng Huang et al. MODERN PATHOLOGY
- Ovarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profiles
- (2013) Melissa K McConechy et al. MODERN PATHOLOGY
- Whole-exome sequencing combined with functional genomics reveals novel candidate driver cancer genes in endometrial cancer
- (2012) H. Liang et al. GENOME RESEARCH
- Loss of ARID1A Expression Is an Early Molecular Event in Tumor Progression From Ovarian Endometriotic Cyst to Clear Cell and Endometrioid Carcinoma
- (2012) Ayse Ayhan et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Loss of ARID1A/BAF250a-expression in endometriosis: a biomarker for risk of carcinogenic transformation?
- (2012) Eleftherios P Samartzis et al. MODERN PATHOLOGY
- Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes
- (2012) Zhi Jiang Zang et al. NATURE GENETICS
- Decreased Expression of the ARID1A Gene Is Associated with Poor Prognosis in Primary Gastric Cancer
- (2012) Dan-dan Wang et al. PLoS One
- Does the Loss of ARID1A (BAF-250a) Expression in Endometrial Clear Cell Carcinomas Have Any Clinicopathologic Significance? A Pilot Assessment
- (2012) Oluwole Fadare et al. Journal of Cancer
- Mutation and Loss of Expression of ARID1A in Uterine Low-grade Endometrioid Carcinoma
- (2011) Bin Guan et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Loss of ARID1A-Associated Protein Expression is a Frequent Event in Clear Cell and Endometrioid Ovarian Cancers
- (2011) William J. Lowery et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- PIK3CA mutations and loss of ARID1A protein expression are early events in the development of cystic ovarian clear cell adenocarcinoma
- (2011) Sohei Yamamoto et al. VIRCHOWS ARCHIV
- Clinicopathological Significance of Loss of ARID1A Immunoreactivity in Ovarian Clear Cell Carcinoma
- (2010) Daichi Maeda et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Chromatin remodelling during development
- (2010) Lena Ho et al. NATURE
- ARID1AMutations in Endometriosis-Associated Ovarian Carcinomas
- (2010) Kimberly C. Wiegand et al. NEW ENGLAND JOURNAL OF MEDICINE
- Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma
- (2010) Siân Jones et al. SCIENCE
- Frequent Activating Mutations of PIK3CA in Ovarian Clear Cell Carcinoma
- (2009) Kuan-Ting Kuo et al. AMERICAN JOURNAL OF PATHOLOGY
- Mechanisms of chemoresistance and poor prognosis in ovarian clear cell carcinoma
- (2008) Hiroaki Itamochi et al. CANCER SCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More